Publication:
Significantly Lower Serum Adiponectin Levels in the Postmenopausal Age may be Specific for Breast Cancer Risk

dc.contributor.authorAKSOY, TURGUT
dc.contributor.authorTrabulus, Didem Can
dc.contributor.authorAral, Hale
dc.contributor.authorSerin, Erdinc
dc.contributor.authorTalu, Canan Kelten
dc.contributor.institutionauthorAKSOY, TURGUT
dc.date.accessioned2020-10-21T20:29:13Z
dc.date.available2020-10-21T20:29:13Z
dc.date.issued2020-09-01T00:00:00Z
dc.description.abstractIntroduction: To date, biomarkers have played a minimal role in the early diagnosis of breast cancer. Although its effects on metabolism are not well known, studies have shown that hypoadiponectinaemia is associated with increased insulin resistance and risk for type-2 diabetes. We aimed to investigate the value of adiponectin together with laboratory results, anthropometric measurements and histopathological findings in assessing the risk of breast cancer and for use in early diagnosis.
dc.identifier.citationAKSOY T., Trabulus D. C. , Aral H., Serin E., Talu C. K. , -Significantly Lower Serum Adiponectin Levels in the Postmenopausal Age may be Specific for Breast Cancer Risk-, ISTANBUL MEDICAL JOURNAL, cilt.21, ss.355-361, 2020
dc.identifier.doi10.4274/imj.galenos.2020.92979
dc.identifier.trdizintrdizin
dc.identifier.urihttp://hdl.handle.net/20.500.12645/23491
dc.identifier.wosWOS:000567757400005
dc.titleSignificantly Lower Serum Adiponectin Levels in the Postmenopausal Age may be Specific for Breast Cancer Risk
dc.typeArticle
dspace.entity.typePublication
local.avesis.id1e83cea5-764c-47c1-8d0b-c291ed3efc1b
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication1f034855-7806-4866-bdf5-fd799db3dda3
relation.isAuthorOfPublication.latestForDiscovery1f034855-7806-4866-bdf5-fd799db3dda3
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files